Pharmaceuticals and Drug Development Access Denied Access Denied You don’t have permission to access ” on this server. Reference #18.b0ed217.1764670323.277f7c81 Written by Admin December 2, 2025December 2, 2025 Saving Bookmark this article Bookmarked
Pharmaceuticals and Drug Development Celcuity Announces Completion of Submission of Its New Drug Application to the U.S. FDA for Gedatolisib in HR+/HER2-/PIK3CA Wild-Type Advanced Breast Cancer MINNEAPOLIS, Nov. 17, 2025 (GLOBE NEWSWIRE) — Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the completion of the submission of its New Drug Application… Written by Admin November 26, 2025November 26, 2025 Saving Bookmark this article Bookmarked
Pharmaceuticals and Drug Development Access Denied Access Denied You don’t have permission to access ” on this server. Reference #18.1d6d3e17.1763633387.dc32c6e Written by Admin November 20, 2025November 20, 2025 Saving Bookmark this article Bookmarked
Pharmaceuticals and Drug Development IChemE announces 2023 Global Awards finalists More than 100 people and projects demonstrating excellence in chemical, biochemical and process engineering are in the final running for the coveted trophies, widely recognised as the world’s most prestigious chemical engineering awards. The 2023 IChemE Global Awards will be held at the Hilton Metropole Birmingham, UK, on 30 November. The evening is one of […] Written by Elsevier Ltd, The Boulevard, Langford Lane, Kidlington, Oxford, OX5 1GB, United Kingdom November 14, 2025November 14, 2025 Saving Bookmark this article Bookmarked
Pharmaceuticals and Drug Development Access Denied Access Denied You don’t have permission to access ” on this server. Reference #18.1d6d3e17.1762596364.1de86408 Written by Admin November 8, 2025November 8, 2025 Saving Bookmark this article Bookmarked
Pharmaceuticals and Drug Development Replimune Announces FDA Acceptance of BLA Resubmission of RP1 for the Treatment of Advanced Melanoma WOBURN, Mass., Oct. 20, 2025 (GLOBE NEWSWIRE) — Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that the U.S. Food and Drug Administration… Written by Admin November 2, 2025November 2, 2025 Saving Bookmark this article Bookmarked
Pharmaceuticals and Drug Development Access Denied Access Denied You don’t have permission to access ” on this server. Reference #18.2d6d3e17.1761559312.1da40cd0 Written by Admin October 27, 2025October 27, 2025 Saving Bookmark this article Bookmarked
Pharmaceuticals and Drug Development Discovery Park welcomes decision to re-join EU Horizon science programme This international collaboration brings together the brightest minds in the world and offers transformational funding that will be vital to drive scientific discovery. Positioned in Kent at the interface of the UK and Europe, Discovery Park is home to a wide range of companies driving scientific development who will benefit from the opportunities this programme […] Written by Elsevier Ltd, The Boulevard, Langford Lane, Kidlington, Oxford, OX5 1GB, United Kingdom October 21, 2025October 21, 2025 Saving Bookmark this article Bookmarked
Pharmaceuticals and Drug Development Access Denied Access Denied You don’t have permission to access ” on this server. Reference #18.1d6d3e17.1760522433.ed999 Written by Admin October 15, 2025October 15, 2025 Saving Bookmark this article Bookmarked
Pharmaceuticals and Drug Development Sentynl Therapeutics Updates On Its NDA for CUTX-101 Solana Beach, CA – OCTOBER 1, 2025 – Sentynl Therapeutics, Inc. (“Sentynl”), a U.S.-based biopharmaceutical company wholly-owned by Zydus Lifesciences, Ltd. (“Zydus”), announced today that the U.S. Food and Drug… Written by Admin October 9, 2025October 9, 2025 Saving Bookmark this article Bookmarked
High-resolution mapping of the actin fusion focus reveals myosin V–dependent formin transport for aster formation Many processes such as polarized growth and secretion require specific actin networks. In fungi, cell–cell fusion requires cell wall digestion mediated by local secretion of lytic enzymes. In Schizosaccharomyces pombe, the myosin V Myo52 transports enzyme-containing secretory vesicles on the actin fusion focus, an aster-like actin network assembled by the condensate-forming formin Fus1. The fusion […] Written by Admin December 4, 2025December 4, 2025 Saving Bookmark this article Bookmarked
The hidden harm from salmon farming In addition to parasites, pathogens, chemical residues, and other treatments can persist in cages. Fallow sites are expected to undergo complete removal of fish and nets to limit pathogen carryover. Campaigners, however, say the Aird site “continued functioning as a reservoir of disease and flesh-eating lice.” Read: The catch. Unsustainable Abigail Penny, executive director of […] Written by brendan December 4, 2025December 4, 2025 Saving Bookmark this article Bookmarked
High-resolution mapping of the actin fusion focus reveals myosin V–dependent formin transport for aster formation Many processes such as polarized growth and secretion require specific actin networks. In fungi, cell–cell fusion requires cell wall digestion mediated by local secretion of lytic enzymes. In Schizosaccharomyces pombe, the myosin V Myo52 transports enzyme-containing secretory vesicles on the actin fusion focus, an aster-like actin network assembled by the condensate-forming formin Fus1. The fusion […] Written by Admin December 4, 2025December 4, 2025 Saving Bookmark this article Bookmarked
The hidden harm from salmon farming In addition to parasites, pathogens, chemical residues, and other treatments can persist in cages. Fallow sites are expected to undergo complete removal of fish and nets to limit pathogen carryover. Campaigners, however, say the Aird site “continued functioning as a reservoir of disease and flesh-eating lice.” Read: The catch. Unsustainable Abigail Penny, executive director of […] Written by brendan December 4, 2025December 4, 2025 Saving Bookmark this article Bookmarked
Doomed ants send a final scent to save their colony Ant societies behave like tightly integrated “superorganisms,” where thousands of individuals work together in a way that resembles the coordinated activity of cells in a body. Researchers at the Institute of Science and Technology Austria (ISTA) have found that terminally ill ant brood release a distinctive odor, similar to the way infected body cells send […] Written by Admin December 4, 2025December 4, 2025 Saving Bookmark this article Bookmarked
Understanding PMDA Validation Rules v5.0 The Pharmaceuticals and Medical Devices Agency (PMDA) in Japan has always led the charge in ensuring the safety and efficacy of drug development. Their latest update, the PMDA Validation Rules version 5.0, which took effect on April 1, 2024, marks another significant step in this mission. Let’s break down what these new rules mean and […] Written by Admin July 10, 2024July 10, 2024 Saving Bookmark this article Bookmarked
Enhance Your SEND Submissions! Join PointCross on May 29th, 2024, at 12 PM EST / 9 AM PST for a must-attend webinar: The Most Common Issues in Preparing SEND. Ideal for professionals in data submission and regulatory compliance, this webinar offers valuable insights from our seasoned experts. Why Attend? Why PointCross? With over 10 years of experience and more […] Written by Admin May 23, 2024May 23, 2024 Saving Bookmark this article Bookmarked